Hyderabad based
During the quarter, export sales of Lenalidomide product to
(C) 2022 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
986 INR | -0.40% | +0.14% | +21.58% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Hyderabad based
During the quarter, export sales of Lenalidomide product to
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+21.58% | 2.12B | |
+31.84% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.32% | 239B | |
+10.03% | 210B | |
-6.95% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |